Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Efectividad de Saccharomyces Oulardii Para Reducir Los síntomas Gastrointestinales y Evitar el Sobrecrecimiento Bacteriano en Esclerosis sistémica

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03692299
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:12.974666+00:00
Published At
2019-07-30T00:00:00+00:00
Record Updated At
2019-07-30
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Systemic Sclerosis", "Small Intestinal Bacterial Overgrowth"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-07-30"
protocolSection.identificationModule.nctId
"NCT03692299"
protocolSection.identificationModule.officialTitle
"Efectividad de Saccharomyces Oulardii Para Reducir Los s\u00edntomas Gastrointestinales y Evitar el Sobrecrecimiento Bacteriano en Esclerosis sist\u00e9mica"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Systemic Sclerosis (protocolSection.conditionsModule.conditions)
  • Small Intestinal Bacterial Overgrowth (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.